Moreover, immunofluorescence analysis of bone marrow samples from both pretreatment and post‐treatment myeloma patients demonstrated elevated expression of SEI1 and PD‐L1 in the myeloma cells of the post‐treatment group (Figure 4Q). The gene discussed is SERTAD1; the disease is plasma cell myeloma.